Back to Search
Start Over
PF595 POMALIDOMIDE + BORTEZOMIB + LOW-DOSE DEXAMETHASONE AFTER ONE PRIOR LINE OF THERAPY IN PATIENTS WITH LENALIDOMIDE-PRETREATED MULTIPLE MYELOMA: SUBGROUP ANALYSIS OF THE PHASE 3 OPTIMISMM TRIAL
- Source :
- HemaSphere. 3:250-251
- Publication Year :
- 2019
- Publisher :
- Ovid Technologies (Wolters Kluwer Health), 2019.
Details
- ISSN :
- 25729241
- Volume :
- 3
- Database :
- OpenAIRE
- Journal :
- HemaSphere
- Accession number :
- edsair.doi...........0c532831fb70eb7677829fef209de285